{"disease":{"id":"pro-opiomelanocortin-pomc-deficiency-obesity","name":"pro opiomelanocortin pomc deficiency obesity"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02896192","title":"Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Rhythm Pharmaceuticals, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}